Regor Pharma, a Shanghai-Boston biotech, sold global rights to Genentech for two early-stage CDK inhibitors aimed at breast cancer. Read more here. ( read original story ...)
Chinese yuan use up 21.1% in cross-border trade as Beijing pushes global role for currency
China’s central bank vows to support Shanghai and Hong Kong as finance centres as it takes ‘next step’ in internationalisation of the yuan. ( read original story ...)
Shanghai, Shenzhen stock exchanges to run test to ensure smooth trading amid transaction surge
China's Shanghai and Shenzhen stock exchanges will reportedly conduct a series of tests on their platforms on Monday to ensure a smoother trading experience, as the combined turnover of the two ... ( read original story ...)
Total of 5,358 listed companies on Chinese stock market by end August: data
This shows an exterior view of the Shanghai Stock Exchange in Shanghai, east China. (Xinhua) There were 5,358 companies listed on the Chinese domestic stock market by t ( read original story ...)
Capital markets: For all the right reasons, is India the new China?
With Swiggy and Hyundai Motor India filing for big-ticket IPOs, India’s primary capital markets are on a tear. This could be the best year for listings in its history. Can it continue? A useful ... ( read original story ...)
China to cut existing mortgage rates by the end of October
China's central bank said on Sunday it would tell banks to lower mortgage rates for existing home loans before Oct. 31, as part of sweeping policies to support the country's beleaguered property ... ( read original story ...)
China’s largest NOR Flash manufacturer receives IPO approval
XMC, a leading Chinese semiconductor manufacturer specializing in NOR Flash memory chips, has received approval for its IPO on the Shanghai Stock Exchange's STAR Market, one of the few instances of ... ( read original story ...)